1. Home
  2. Material Detail: Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

Material Detail

"Efficacy of Tocilizumab in Patients Hospitalized with Covid-19" icon

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

This study discusses the efficacy of tocilizumab in non-vented patients diagnosed with Coronavirus Disease 2019 (COVID-19).  

Keywords:
Infectious disease, Nursing, Medicine, Tocilizumab, inflammation, Pathophysiology, Interleukin, Pharmacology, COVID-19
Disciplines:
Go to Material 
Bookmark / Add to Course ePortfolio
Create a Learning Exercise
Add Accessibility Information
Rate
Add a Comment

Quality

  • User Rating
  • Comments
  • Learning Exercises
  • Bookmark Collections
  • Course ePortfolios
  • Accessibility Info

More about this material

Material Type:
Open (Access) Journal-Article
Date Added to MERLOT:
March 9, 2021
Date Modified in MERLOT:
March 9, 2021
Authors:









Submitter:
Brendan Shull
Primary Audience:
Professional
Technical Format:
PDF, Website
Mobile Compatibility:
Not specified at this time
Language:
English
Cost Involved:
No
Source Code Available:
Yes
Accessibility Information Available:
Unknown
Creative Commons:
Unknown

Browse...

Disciplines with similar materials as Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
People who viewed this also viewed
Other materials like Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

Comments

Log in to participate in the discussions or sign up if you are not already a MERLOT member.